Skip to content
PD-MitoQUANT Logo PD-MitoQUANT Logo PD-MitoQUANT Logo
  • HOME
  • PROJECT
    • Publications
      • Related Publications
    • PUBLIC DELIVERABLES
    • PUBLISHABLE SUMMARY
    • VACANCIES
    • Neuronet – Related Projects
  • TEAM
    • Meet our Early- & Mid-Career Researchers
    • Meet our Partners
      • RCSI (The Royal College of Surgeons in Ireland – University of Medicine and Health Sciences)
      • Institut du Cerveau – Paris Brain Institute (ICM)
      • German Center for Neurodegenerative Diseases (DZNE)
      • University College London (UCL)
      • Radboud University Nijmegen Medical Centre (RUMC)
      • Centre National de la Recherche Scientifique (CNRS)
      • GeneXplain GmbH (geneXplain)
      • Mimetas
      • Pintail Limited (PT)
      • Teva Pharmaceutical Industries Ltd. (TEVA)
      • Lundbeck
      • UCB S.A. (UCB)
      • Parkinson’s UK
  • GENERAL PUBLIC
    • Informational videos
    • Publication Summaries
  • MEDIA
  • NEWS
  • ResearchGate

Screenshot 2022-09-09 at 12.02.38

pdmq_admin2022-09-09T12:04:58+01:00September 9th, 2022|

Recent Posts

  • Publication news from DZNE
  • Check out our final newsletter!
  • Review article from DZNE published in The Lancet
  • New PD-MitoQUANT research published in IEEE conference proceedings
  • Parting Thoughts from our Public Patient Involvement Volunteers

Tags

conference dissemination DZNE Event Neuronet newsletter new team member online outreach Partner in the Spotlight plenary poster PPI presentation press release Publication PwP SME

PROJECT FACTS

 

  • Grant agreement number 821522
  • IMI2 JU contribution €4,617,933.75
  • Duration 36 months
  • Starting date 1 February 2019

 

#pdmitoquant on Twitter

IHIEurope avatar; Innovative Health Initiative @IHIEurope ·
14 Mar 2023 1635659631115501571

IMI projects like #PDMitoQUANT, ADAPTED, IMPRIND and PHAGO addressed the molecular underpinnings of #Parkinson's and #Alzheimer’s disease, translating their findings into new tools, assays & platforms.
More on our impacts: http://bit.ly/3vVJjwo
#BAW2023 #BrainAwarenessWeek

Image for the Tweet beginning: IMI projects like #PDMitoQUANT, ADAPTED, Twitter feed video.
PintailLimited avatar; Pintail Limited @PintailLimited ·
9 Sep 2022 1568212559106396166

Neuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreading #PDMitoQUANT @IHIEurope @IMI2_NEURONET @DZNE_en https://www.science.org/doi/10.1126/sciadv.abn0356#.YxsvHk1CZ0k.twitter

FUNDING ACKNOWLEDGEMENT

 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821522. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

The material presented and views expressed here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

Copyright 2019-   PD-MitoQUANT | All rights reserved | Privacy Policy
Page load link
Go to Top